HALEOSLABS
HALEOS LABS LIMITED (HALEOSLABS) Stock Analysis
HALEOS LABS LIMITED is an Indian life sciences or diagnostics company developing laboratory products and services. It focuses on research, testing, or biotech solutions for healthcare customers. The company is a recently listed entity in the healthcare space. It is listed on Indian stock exchanges.
Healthcare › Biotechnology
₹1,500.00
+2.56% 1W | +20.40% 52W
Market Cap
453 CR
P/E Ratio
28.7
52W High
₹1774
52W Low
₹1091.1
Div. Yield
0.1%
Beta
0.3
50 DMA
₹1504.3
200 DMA
₹1396.3
Profit Margin
4.9%
Inst. Own.
0%
🚀 BREAKOUT
🚀 BREAKOUT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 74.65 | 69.26 | 72.05 | 89.99 | 92.55 | 78.46 | 84.60 | 89.11 | 82.50 | 81.37 | 94.78 | 75.14 | 72.94 |
| Expenses | 72.11 | 61.33 | 62.75 | 78.63 | 76.27 | 69.89 | 71.85 | 81.69 | 70.79 | 67.79 | 80.73 | 70.98 | 63.82 |
| Operating Profit | 2.54 | 7.93 | 9.30 | 11.36 | 16.28 | 8.57 | 12.75 | 7.42 | 11.71 | 13.58 | 14.05 | 4.16 | 9.12 |
| OPM % | 3.40% | 11.45% | 12.91% | 12.62% | 17.59% | 10.92% | 15.07% | 8.33% | 14.19% | 16.69% | 14.82% | 5.54% | 12.50% |
| Other Income | 0.61 | 0.27 | 0.58 | 2.36 | 0.44 | 2.04 | 0.06 | 2.34 | 1.00 | 0.42 | 0.18 | 2.01 | 0.46 |
| Interest | 2.18 | 2.81 | 2.34 | 2.84 | 2.40 | 2.14 | 2.14 | 2.03 | 1.87 | 1.62 | 1.54 | 1.42 | 1.90 |
| Depreciation | 3.70 | 3.73 | 3.73 | 3.78 | 3.68 | 3.76 | 3.76 | 3.80 | 3.82 | 3.89 | 3.91 | 3.85 | 4.24 |
| Profit before tax | -2.73 | 1.66 | 3.81 | 7.10 | 10.64 | 4.71 | 6.91 | 3.93 | 7.02 | 8.49 | 8.78 | 0.90 | 3.44 |
| Tax % | 40.29% | 126.51% | -8.14% | 8.73% | 33.27% | 29.72% | 29.81% | 11.45% | 37.61% | 24.38% | 24.26% | 62.22% | 46.51% |
| Net Profit | -3.83 | -0.44 | 4.12 | 6.47 | 7.10 | 3.30 | 4.86 | 3.48 | 4.39 | 6.42 | 6.65 | 0.35 | 1.84 |
| EPS in Rs | -5.95 | 2.25 | 14.22 | 19.52 | 23.15 | 15.45 | 18.09 | 9.82 | 13.76 | 20.18 | 21.90 | 1.46 | 8.77 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 378 | 261 | 266 | 350 | 316 | 306 | 345 | 334 | 324 |
| Expenses | 343 | 235 | 235 | 316 | 287 | 275 | 300 | 289 | 283 |
| Operating Profit | 35 | 25 | 30 | 35 | 29 | 31 | 45 | 45 | 41 |
| OPM % | 9% | 10% | 11% | 10% | 9% | 10% | 13% | 13% | 13% |
| Other Income | 2 | 2 | 2 | 14 | 5 | 4 | 5 | 2 | 3 |
| Interest | 6 | 5 | 5 | 6 | 7 | 10 | 9 | 6 | 6 |
| Depreciation | 6 | 8 | 8 | 10 | 11 | 15 | 15 | 15 | 16 |
| Profit before tax | 25 | 15 | 20 | 33 | 17 | 10 | 26 | 25 | 22 |
| Tax % | 30% | 31% | 31% | 23% | 31% | 36% | 28% | 29% | |
| Net Profit | 18 | 10 | 14 | 25 | 11 | 6 | 19 | 18 | 15 |
| EPS in Rs | 59.04 | 33.67 | 44.85 | 83.75 | 37.91 | 30.07 | 66.52 | 57.26 | 52.31 |
| Dividend Payout % | 3% | 0% | 3% | 2% | 4% | 5% | 2% | 3% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 2.0% | 5.0% | – |
| Profit CAGR | 20.0% | 5.0% | – |
Shareholding Pattern
Promoters71.40%
FIIs0.03%
Public28.56%
Promoters71.40%
DIIs0.03%
Public28.57%
Promoters71.79%
DIIs0.29%
Public27.91%
Promoters72.10%
DIIs0.30%
Public27.59%
Promoters72.10%
DIIs0.31%
Public27.58%
Promoters70.32%
Public29.67%
Promoters71.19%
Public28.81%
Promoters71.40%
Public28.60%
Promoters72.10%
DIIs0.30%
Public27.59%
Promoters72.10%
DIIs0.31%
Public27.58%
HALEOSLABS
Holdings Analysis
Key strengths & risk signals
63
Overall
59
Fundamental
68
Technical
Risks (3)
LOW MARGIN! 4.9% profit margin - thin profits.
RECOVERY MODE! Current price (1500.0) above 200-day but below 50-day.
BEARISH SENTIMENT! In last 30 days: 20 up days, 10 down days. Avg volume on up days: 839 vs down days: 1,247. Ratio: 0.67x
Strengths (4)
FAIRLY VALUED! PEG of 1.95 indicates reasonable valuation.
BULLISH TREND! 50-day average (1504.3) is above 200-day average (1396.3) - positive signal.
BREAKOUT! Stock has broken above resistance levels with momentum.
STRONG MOMENTUM! Price has grown across all timeframes - up 2.6% (1 week), 4.3% (1 month), 9.0% (3 months). Momentum is accelerating.
Fundamental & Technical Analysis
63Overall
59Fundamental
68Technical
Fundamental Breakdown
Growth Quality
16/30
Revenue CAGR: 0.3% (SLOW, 5/15). Profit CAGR: 14.7% (GOOD, 11/15).
Profit Margin
2/10
LOW MARGIN! 4.9% profit margin - thin profits.
PEG Valuation
8/10
FAIRLY VALUED! PEG of 1.95 indicates reasonable valuation.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.1% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 29.68% public ownership - balanced ownership structure.
Stability Index
6/10
MODERATE STABILITY! 2 revenue dips in history. Acceptable but monitor closely.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1504.3) is above 200-day average (1396.3) - positive signal.
Price Position
2/10
RECOVERY MODE! Current price (1500.0) above 200-day but below 50-day.
Trend Pattern
20/20
BREAKOUT! Stock has broken above resistance levels with momentum.
52W Performance
8/10
GOOD YEAR! Stock gained 20.4% in the last year.
Volume Sentiment
10/30
BEARISH SENTIMENT! In last 30 days: 20 up days, 10 down days. Avg volume on up days: 839 vs down days: 1,247. Ratio: 0.67x
RSI
3/5
NEUTRAL! RSI at 53.0 - balanced momentum.
52W Range
3/5
MID RANGE! Trading at 59.9% of 52W range - neutral zone.
Momentum
5/5
STRONG MOMENTUM! Price has grown across all timeframes - up 2.6% (1 week), 4.3% (1 month), 9.0% (3 months). Momentum is accelerating.
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
Peer Comparison
Healthcare · Biotechnology · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HALEOSLABS | ₹1,500.00 | 28.7 | 4.9% | 0.3% | 14.7% | +20.4% | 63 | BREAKOUT | -38.1% | +550.0% | -11.6% | -2.9% |
| LYKALABS | ₹85.00 | – | -6.6% | 13.3% | – | -16.4% | 59 | CONSOLIDATING UP | +133.3% | -127.6% | +28.2% | +51.1% |
| PANACEABIO | ₹375.30 | – | -1.1% | 11.9% | – | -10.0% | 50 | CONSOLIDATING DOWN | -42.5% | +360.0% | +19.7% | +19.7% |
| DCAL | ₹170.90 | 27.5 | 0.6% | 9.0% | 21.0% | -45.8% | 52 | APPROACHING SUPPORT | -347.9% | -367.3% | -4.2% | -20.4% |
| ZOTA | ₹1,287.80 | – | -17.0% | 56.7% | – | -19.5% | 49 | BOUNCE FROM SUPPORT | +204.9% | +207.0% | +67.6% | +6.4% |
| 3BBLACKBIO | ₹1,410.00 | 21.2 | 36.3% | 31.9% | 32.2% | +14.9% | 67 | APPROACHING RESISTANCE | -24.6% | -1.0% | +50.9% | -5.4% |
| SUPRIYA | ₹957.10 | 38.8 | 22.7% | 21.2% | 32.5% | +21.3% | 79 | BREAKOUT | -31.0% | -67.7% | +30.7% | -31.4% |
| BLUEJET | ₹580.20 | 42.9 | 26.5% | 9.4% | 15.7% | -14.0% | 62 | APPROACHING RESISTANCE | -14.1% | +21.8% | -17.4% | +24.9% |
Data from TradeAlone · Updated daily
No news tagged for HALEOSLABS yet.
